World J Gastroenterol (2021) 27:6715
Pooled analyses of SURPASS data suggest that tirzepatide reduced triglycerides by approximately 15-30%, total cholesterol by 5-10%, and LDL cholesterol by 5-8% across various doses, with HDL cholesterol increases of approximately 5-8%
Using such a calculator can make the dosing process more precise and safer, reducing guesswork and helping patients get the most benefit from their treatment
Hostynek JJ, Dreher F, Maibach HI
We observed statistically significant, though modest, improvements in several obesity-related parameters: HbA1c, LDL-C, ALT, and AST levels
They want their body to respond to that work the way it did five or ten years ago